V-CRIMA

Land: Israel

Språk: engelska

Källa: Ministry of Health

Aktiva substanser:

HYDROXYETHYLCELLULOSE; POVIDONE

Tillgänglig från:

VITAMED PHARMACEUTICAL INDUSTRIES LTD

ATC-kod:

S01XA

Läkemedelsform:

SOLUTION

Sammansättning:

POVIDONE 1.65 %; HYDROXYETHYLCELLULOSE 0.4 %

Administreringssätt:

OCULAR

Receptbelagda typ:

Not required

Tillverkad av:

VITAMED LTD, ISRAEL

Terapeutisk grupp:

OTHER OPHTHALMOLOGICALS

Terapeutiska indikationer:

Artificial tears.

Tillstånd datum:

2022-01-31

Bipacksedel

q³� s� U1⁄4«u²×� h×�Ë …dAM�« Ác1⁄4 X�œu�
.W×B�« …—«“Ë
W�ŒUOB�« WLE1⁄2« V�Š PKN²�LK� …DA1⁄2
±Π∏∂© «DCײ��®
‰ULF²ÝUÐ ¡b³�« q³� W¹UNM�« v²Š ÊUF�UÐ
…dAM�« √d�«
.¡«Ëb�«
The format of this leaflet was set by the
Ministry of Health who checked and
approved its content.
PATIENT PACKAGE INSERT
IN AC CORD
ANCE WITH THE
PHARMACISTS' REG
ULA TIONS
(PREPARATIONS), 1986
Read this package insert carefully in its
entirety before using this medicine.
˙‡ȯ·‰ „¯˘Ó È”Ú Ú·˜È ‰Ê ÔÂÏÚ
ËÓ¯ÂÙ
ÆÂ„È ÏÚ ¯˘Â‡Â ˜„·È ÂÎÂ˙Â
ÌÈÁ˜Â¯‰ ˙Â˜˙ ÈÙÏ ÔίˆÏ ÔÂÏÚ
±Π∏∂≠Â¢Ó˘˙‰ ®ÌÈ¯È˘Î˙©
̯˷ ÂÙÂÒ „Ú ÔÂÏÚ‰ ˙‡ ÔÂÈÚ· ‡¯˜
ƉÙ¯˙· ˘Ó˙˘˙
V-CRIMA,
EYE DROPS
COMPOSITION: Polyvinyl Pyrrolidone 1.65%,
Hydroxy Ethyl Cellulose 0.4%
INACTIVE
INGREDIENTS:
Boric
Acid,
Borax,
EDTA Disodium, Benzalkonium Cl. 50% Sol.,
Purfied water.
INDICATIONS: Artificial tears.
WHEN
SHOULD
THE
PREPARATION
NOT
BE
USED?
Do
not
use
this
medicine
if
you
are
sensitive to any of its ingredients. Do not
use this medicine if it changes color or if
it turns turbid.
WARNINGS: If you are sensitive to any type of
food or medicine, inform your doctor before
commencing treatment with this medicine.
The
medicine
contains
the
preservative
Benzalkonium Chloride that can be absorbed
by
soft
contact
lenses.
Do
not
use
this
medicine
when
soft
contact
lenses
are
inserted in your eyes. Remove contact lenses
before using this medicine and reinsert into
your eyes not less than 15 minutes after use
of the medicine.
EFFECTS THAT REQUIRE SPECIAL ATTENTION:
In
case
of
changes
in
sight,
eye
pain,
irritation, continuous redness in the eye (rare)
- stop treatment and refer to your doctor.
In the event that you experience side effects
not mentioned in this leaflet,
or if
there is a
change in your general health, consult your
doctor immediately.
ADVER